Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Revascularization With Modification Using Definitive IVL and Serration Remodeling for Optimal Lumen

NCT: NCT07575568 · NOT_YET_RECRUITING

NCT IDNCT07575568
StatusNOT_YET_RECRUITING
Start Date2026-05
Completion2027-09

Brief Summary

The objective of this first-in-human study is to assess the safety and effectiveness of the Serranator Sonic Intravascular Lithotripsy (IVL) System™ for the treatment of peripheral artery disease.

Frequently Asked Questions

What is Revascularization With Modification Using Definitive IVL and Serration Remodeling for Optimal Lumen?

Revascularization With Modification Using Definitive IVL and Serration Remodeling for Optimal Lumen is a clinical trial registered under NCT07575568. Current status: NOT_YET_RECRUITING.

What is the status of NCT07575568?

The current status of NCT07575568 (Revascularization With Modification Using Definitive IVL and Serration Remodeling for Optimal Lumen) is: NOT_YET_RECRUITING.

When did Revascularization With Modification Using Definitive IVL and Serration Remodeling for Optimal Lumen start?

Revascularization With Modification Using Definitive IVL and Serration Remodeling for Optimal Lumen started on 2026-05.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑